|
000
| 01153nam 2200289zi 4500 |
|---|
| 001 | 9.920325 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20240209135304 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 220221s2020 onc o f000 0 mic d |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn--- |
|---|
| 086 | 1 |aHP5-133/16-2020-1Mic-PDF |
|---|
| 245 | 00|aTa oen pepseteo memonalogon emseng COVID–19. |
|---|
| 264 | 1|a[Ottawa] : |bAgence de la santé publique du Canada = Public Health Agency of Canada, |c[2020] |
|---|
| 300 | |a1 online resource (2 pages) |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 546 | |aText in Mi’kmaq. |
|---|
| 650 | 0|aCOVID-19 (Disease)|zCanada|xPrevention. |
|---|
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
|---|
| 775 | 08|tPeople who are at risk of more severe disease or outcomes from COVID-19.|w(CaOODSP)9.902113 |
|---|
| 792 | |tTa oen pepseteo memonalogon emseng COVID–19.|w(CaOODSP)9.920326 |
|---|
| 856 | 40|qPDF|s255 KB|uhttps://publications.gc.ca/collections/collection_2023/aspc-phac/hp5-133/HP5-133-16-2020-1-mic.pdf |
|---|